Oculis Holding AG Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Free Cash Flow -$84.1MTTM through 31 Dec 2025
Margins
| Current |
|---|
Returns
-50.5%ROE
-41.9%ROA
Balance Sheet Health
Debt / Equity0.01x
Current Ratio5.96x
Net Debt-$210.7Mnet cash position
Cash & Equivalents$81.3M
Quality Metrics
Piotroski F-Score3 / 9
Earnings-Beat Rate25.0%
Multi-Year Trend
Diluted EPSFY2025: $-1.89
Dividend
No dividend
Segment Performance
No segment data available.
Financials converted at 0.7917 from CHF.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.